Jonathan Z. Li

Follow

Generating author description...

All published works
Action Title Year Authors
+ Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance 2025 Tin Phan
Ruy M. Ribeiro
Gregory E. Edelstein
Julie Boucau
Rockib Uddin
Caitlin Marino
May Y. Liew
Mamadou Ciré Barry
Manish C. Choudhary
Dessie Tien
+ PDF Chat Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody 2024 Tin Phan
Carolin Zitzmann
Kara W. Chew
Davey M. Smith
Eric S. Daar
David A. Wohl
Joseph J. Eron
Judith S. Currier
Michael D. Hughes
Manish C. Choudhary
+ Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody 2023 Tin Phan
Carolin Zitzmann
Kara W. Chew
Davey M. Smith
Eric S. Daar
David A. Wohl
Joseph J. Eron
Judith S. Currier
Michael D. Hughes
Manish C. Choudhary
+ PDF Chat Variant-Specific Viral Kinetics in Acute COVID-19 2023 Ruy M. Ribeiro
Manish C. Choudhary
Rinki Deo
Mark J. Giganti
Carlee Moser
Justin Ritz
Alexander L. Greninger
James Regan
James P. Flynn
David A. Wohl
+ PDF Chat Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials 2023 Carlee Moser
Kara W. Chew
Mark J. Giganti
Jonathan Z. Li
Evgenia Aga
Justin Ritz
Alexander L. Greninger
Arzhang Cyrus Javan
Rachel Bender Ignacio
Eric S. Daar
+ PDF Chat Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection 2023 Rinki Deo
Manish C. Choudhary
Carlee Moser
Justin Ritz
Eric S. Daar
David A. Wohl
Alexander L. Greninger
Joseph J. Eron
Judith S. Currier
Michael D. Hughes
+ PDF Chat Viral and Symptom Rebound in Untreated COVID-19 Infection 2022 Rinki Deo
Manish C. Choudhary
Carlee Moser
Justin Ritz
Eric S. Daar
David A. Wohl
Alexander L. Greninger
Joseph J. Eron
Judith S. Currier
Michael D. Hughes
+ Uncovering hidden sources of SARS‐CoV‐2 viral evolution: A call to action 2022 Manish C. Choudhary
Jonathan Z. Li
+ PDF Chat Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination 2021 Crystal M. North
Amy K. Barczak
Robert H. Goldstein
Brian C. Healy
Dianne M. Finkelstein
Delaney D Ding
Andy Kim
Julie Boucau
Bennett Shaw
Rebecca F. Gilbert
+ PDF Chat Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019 2021 James Regan
James P. Flynn
Alexandra Rosenthal
Hannah Jordan
Yijia Li
Rida Chishti
Françoise Giguel
Heather Corry
Kendyll Coxen
Jesse Fajnzylber
+ Uncovering Ways That Emerging Severe Acute Respiratory Syndrome Coronavirus 2 Lineages May Increase Transmissibility 2021 Jacob E. Lemieux
Jonathan Z. Li
+ PDF Chat SARS-CoV-2 viral load is associated with increased disease severity and mortality 2020 Jesse Fajnzylber
James Regan
Kendyll Coxen
Heather Corry
Colline Wong
Alexandra Rosenthal
Daniel Worrall
Françoise Giguel
Alicja Piechocka‐Trocha
Caroline Atyeo
Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ PDF Chat Temporal dynamics in viral shedding and transmissibility of COVID-19 2020 Xi He
Eric H. Y. Lau
Peng Wu
Xilong Deng
Jian Wang
Xinxin Hao
Yiu Chung Lau
Jessica Y. Wong
Yujuan Guan
Xinghua Tan
4
+ In vivo kinetics of SARS-CoV-2 infection and its relationship with a person’s infectiousness 2021 Ruian Ke
Carolin Zitzmann
David D. Ho
Ruy M. Ribeiro
Alan S. Perelson
4
+ Mechanistic Modeling of SARS‐CoV‐2 and Other Infectious Diseases and the Effects of Therapeutics 2021 Alan S. Perelson
Ruian Ke
4
+ Modeling the viral dynamics of SARS-CoV-2 infection 2020 Sunpeng Wang
Yang Pan
Quanyi Wang
Hongyu Miao
Ashley N. Brown
Libin Rong
3
+ PDF Chat How robust are estimates of key parameters in standard viral dynamic models? 2024 Carolin Zitzmann
Ruian Ke
Ruy M. Ribeiro
Alan S. Perelson
3
+ PDF Chat An explanation for SARS-CoV-2 rebound after Paxlovid treatment 2023 Alan S. Perelson
Ruy M. Ribeiro
Tin Phan
3
+ A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2 2021 Kwang Su Kim
Keisuke Ejima
Shoya Iwanami
Yasuhisa Fujita
Hirofumi Ohashi
Yoshiki Koizumi
Yusuke Asai
Shinji Nakaoka
Koichi Watashi
Kazuyuki Aihara
3
+ PDF Chat Identifiability of parameters in mathematical models of SARS-CoV-2 infections in humans 2022 Stanca M. Ciupe
Necibe Tuncer
3
+ PDF Chat Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness 2022 Ruian Ke
Pamela P. Martinez
Rebecca L. Smith
Laura Gibson
Agha Zeeshan Mirza
Madison Conte
Nicholas Gallagher
Chun Huai Luo
Junko Jarrett
Ruifeng Zhou
3
+ PDF Chat SARS-CoV-2 viral load is associated with increased disease severity and mortality 2020 Jesse Fajnzylber
James Regan
Kendyll Coxen
Heather Corry
Colline Wong
Alexandra Rosenthal
Daniel Worrall
Françoise Giguel
Alicja Piechocka‐Trocha
Caroline Atyeo
3
+ In-host Mathematical Modelling of COVID-19 in Humans 2020 Esteban A. HernĂĄndez-Vargas
Jorge X. Velasco‐Hernández
3
+ The within-host viral kinetics of SARS-CoV-2 2020 Chentong Li
Jinhu Xu
Jiawei Liu
Yicang Zhou
2
+ Multimodel Inference 2004 Kenneth P. Burnham
David R. Anderson
2
+ Emergence of Drug Resistance during an Influenza Epidemic: Insights from a Mathematical Model 1998 Nikolaos I. Stilianakis
Alan S. Perelson
Frederick G. Hayden
2
+ PDF Chat Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data 2020 Natalie M. Linton
T. Kobayashi
Yichi Yang
Katsuma Hayashi
Andrei R. Akhmetzhanov
Sung-mok Jung
Baoyin Yuan
Ryo Kinoshita
Hiroshi Nishiura
2
+ PDF Chat The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application 2020 Stephen A. Lauer
Kyra H. Grantz
Qifang Bi
Forrest K. Jones
Qulu Zheng
Hannah R. Meredith
Andrew S. Azman
Nicholas G Reich
Justin Lessler
2
+ SARS-CoV-2 (COVID-19) by the numbers 2020 Yinon M. Bar-On
Avi I. Flamholz
Rob Phillips
Ron Milo
2
+ Mathematical modeling of interaction between innate and adaptive immune responses in COVID‐19 and implications for viral pathogenesis 2020 Sean Quan Du
Weiming Yuan
2
+ PDF Chat Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load 2020 Antînio Gonçalves
Julie Bertrand
Ruian Ke
Emmanuelle Comets
Xavier de Lamballerie
Denis Malvy
Andrés Pizzorno
Olivier Terrier
Manuel Rosa‐Calatrava
France Mentré
2
+ Dynamics of SARS-CoV-2 infection model with two modes of transmission and immune response 2020 Khalid Hattaf
Noura Yousfi
2
+ PDF Chat A Model for SARS-CoV-2 Infection with Treatment 2020 Amar Nath Chatterjee
Fahad Al Basir
2
+ Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort 2021 NadĂšge NĂ©ant
Guillaume Lingas
Quentin Le Hingrat
Jade Ghosn
Ilka Engelmann
Quentin Lepiller
Alexandre Gaymard
Virginie Ferré
CĂ©dric Hartard
Jean‐Christophe Plantier
2
+ SARS-CoV-2 viral dynamics in non-human primates 2021 António Gonçalves
Pauline Maisonnasse
Flora Donati
MĂ©lanie Albert
Sylvie Behillil
Vanessa Contreras
Thibaut Naninck
Romain Marlin
Caroline Solas
Andrés Pizzorno
2
+ Comparing antiviral strategies against COVID-19 via multiscale within-host modelling 2021 Farzad Fatehi
Richard J. Bingham
Eric C. Dykeman
Peter G. Stockley
Reidun Twarock
2
+ PDF Chat Modeling within-host and aerosol dynamics of SARS-CoV-2: The relationship with infectiousness 2022 Nora Heitzman-Breen
Stanca M. Ciupe
2
+ Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: A retrospective cohort study 2022 James A. Hay
Stephen M Kissler
Joseph R. Fauver
Christina Mack
Caroline G. Tai
Radhika M Samant
Sarah Connolly
Deverick J. Anderson
Gaurav Khullar
Matthew MacKay
2
+ Effect of cellular regeneration and viral transmission mode on viral spread 2022 Asher Haun
Baylor G. Fain
Hana M. Dobrovolny
2
+ Using statistics and mathematical modelling to understand infectious disease outbreaks: COVID-19 as an example 2020 Christopher E. Overton
Helena B. Stage
Shazaad S.Y. Ahmad
Jacob Curran-Sebastian
Paul Dark
Rajenki Das
Elizabeth Fearon
Timothy Felton
Martyn Fyles
Nick Gent
1
+ PDF Chat Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England 2020 Nicholas G. Davies
Sam Abbott
Rosanna C. Barnard
Christopher Jarvis
Adam J. Kucharski
James D. Munday
Carl A. B. Pearson
Timothy Russell
Damien C. Tully
Alex Washburne
1
+ PDF Chat SARS-CoV-2 Transmission From People Without COVID-19 Symptoms 2021 Michael A. Johansson
TalĂ­a M. Quandelacy
Sarah Kada
Pragati Prasad
Molly Steele
John T. Brooks
Rachel B. Slayton
Matthew Biggerstaff
Jay C. Butler
1
+ PDF Chat Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China 2020 Joseph T. Wu
Kathy Leung
Mary Bushman
Nishant Kishore
René Niehus
Pablo M. De Salazar
Benjamin J. Cowling
Marc Lipsitch
GM Leung
1
+ PDF Chat Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses 2024 Katherine Owens
Shadisadat Esmaeili
Joshua T. Schiffer
1
+ Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events 2021 Ashish Goyal
Daniel B. Reeves
E. FabiĂĄn Cardozo-Ojeda
Joshua T. Schiffer
Bryan T. Mayer
1
+ Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action 2021 Peter Czuppon
Florence DĂ©barre
António Gonçalves
Olivier Tenaillon
Alan S. Perelson
Jérémie Guedj
François Blanquart
1
+ PDF Chat Sharing a household with children and risk of COVID-19: a study of over 300 000 adults living in healthcare worker households in Scotland 2021 Rachael Wood
Emma C. Thomson
Robert M. Galbraith
Ciara Gribben
David Caldwell
Jennifer L. Bishop
Martin Reid
Anoop Shah
Kate Templeton
David Goldberg
1
+ Mixed Effects Models with Censored Data with Application to HIV RNA Levels 1999 James P. Hughes
1
+ SARS-CoV-2 Infection after Vaccination in Health Care Workers in California 2021 Jocelyn Keehner
Lucy E. Horton
Michael A. Pfeffer
Chris Longhurst
Robert T. Schooley
Judith S. Currier
Shira R. Abeles
Francesca J. Torriani
1
+ PDF Chat Causes and Consequences of Spatial Within-Host Viral Spread 2018 Molly E. Gallagher
Christopher B. Brooke
Ruian Ke
Katia Koelle
1
+ PDF Chat Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019 2021 James Regan
James P. Flynn
Alexandra Rosenthal
Hannah Jordan
Yijia Li
Rida Chishti
Françoise Giguel
Heather Corry
Kendyll Coxen
Jesse Fajnzylber
1
+ PDF Chat Prevalence of Asymptomatic SARS-CoV-2 Infection 2020 Daniel P. Oran
Eric J. Topol
1
+ PDF Chat Immune‐viral dynamics modeling for SARS‐CoV‐2 drug development 2021 Youfang Cao
Wei Gao
Luzelena Caro
Julie A. Stone
1
+ A retrospective cohort study of Paxlovid efficacy depending on treatment time in hospitalized COVID-19 patients 2024 Zhanwei Du
Lin Wang
Yuan Bai
Liu Yun-hu
Eric H. Y. Lau
Alison P. Galvani
Robert M. Krug
Benjamin J. Cowling
Lauren Ancel Meyers
1
+ A Modified Poisson Regression Approach to Prospective Studies with Binary Data 2004 Guangyong Zou
1
+ PDF Chat SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape 2022 Sandile Cele
Farina Karim
Gila Lustig
James Emmanuel San
Tandile Hermanus
Houriiyah Tegally
Jumari Snyman
Thandeka Moyo-Gwete
Eduan Wilkinson
Mallory Bernstein
1
+ PDF Chat Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees 2022 Kenichiro Takahashi
Masahiro Ishikane
Mugen Ujiie
Noriko Iwamoto
Nobumasa Okumura
Testsuro Sato
Maki Nagashima
Ataru Moriya
Michiyo Suzuki
Masayuki Hojo
1
+ Analysis and design issues for studies using censored biomarker measurements with an example of viral load measurements in HIV clinical trials 2000 Michael D. Hughes
1
+ Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons 2021 Stephen M. Kissler
Joseph R Fauver
Christina Mack
Caroline G. Tai
Mallery I. Breban
Anne E. Watkins
Radhika M Samant
Deverick J. Anderson
Jessica Metti
Gaurav Khullar
1
+ PDF Chat Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms 2022 Budhaditya Chatterjee
Harshbir Singh Sandhu
Narendra M. Dixit
1
+ PDF Chat Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody 2024 Tin Phan
Carolin Zitzmann
Kara W. Chew
Davey M. Smith
Eric S. Daar
David A. Wohl
Joseph J. Eron
Judith S. Currier
Michael D. Hughes
Manish C. Choudhary
1
+ Epidemiologic Evaluation of Measurement Data in the Presence of Detection Limits 2004 Jay H. Lubin
Joanne S. Colt
David Camann
Scott Davis
James R. Cerhan
Richard K. Severson
Leslie Bernstein
Patricia Hartge
1